 Vyant Bio Inc has announced the appointment of Robert Fremeau as the companys new chief scientific officer. Vyant said Fremeau is an experienced research and development leader with over two decades of drug discovery experience in academia and industry, advancing next-generation drug development for severe neurological disorders. 